Cargando…
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
Uncertainty exists whether mild COVID-19 confers immunity to reinfection. Questions also remain regarding the persistence of antibodies against SARS-CoV-2 after mild infection. We prospectively followed at-risk individuals with and without SARS-CoV-2 for reinfection and monitored the spike and nucle...
Autores principales: | Schuler, Charles F., Gherasim, Carmen, O’Shea, Kelly, Manthei, David M., Chen, Jesse, Zettel, Cristyn, Troost, Jonathan P., Kennedy, Andrew A., Tai, Andrew W., Giacherio, Donald A., Valdez, Riccardo, Baldwin, James L., Baker, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557889/ https://www.ncbi.nlm.nih.gov/pubmed/34468184 http://dx.doi.org/10.1128/Spectrum.00087-21 |
Ejemplares similares
-
Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2
por: Schuler, Charles, et al.
Publicado: (2022) -
Vaccination against COVID-19 Leads to Enhanced Immunity Despite Infection History
por: O'Shea, Kelly, et al.
Publicado: (2022) -
Accurate point-of-care serology tests for COVID-19
por: Schuler, Charles F., et al.
Publicado: (2021) -
Viral Neutralization Against SARS-CoV-2 is More Durable After Infection Versus Vaccination
por: Chen, Kelsea, et al.
Publicado: (2023) -
Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron
por: O’Shea, Daniel, et al.
Publicado: (2023)